DuPont Nutrition & Health and Lonza Specialty Ingredients will partner for the former to make and supply CARE4U 2’-FL – a human milk oligosaccharide (HMOs).###“By engaging strategically with Lonza, DuPont will be able to accelerate commercialization and offer high-quality HMOs to customers and prospects,” said John Rea, global business unit leader, cultures, probiotics, food pzinc gluconate liquidrotection, HMO & Fibers, DuPont Nutrition & Health.###“Partnering with DuPont, Lonza will apply its leading science and biotechnkirkland citrate magnesium and zincology citracal z tabletexpertise in consumer health and nutrition applications to develop and manufacture superior quality human milk oligosaccharide CARE4U 2′-FL,” said Erasmo Schutzer, president of Lonza’s consumer health division.###Naturally present in human milk, HMOs have been shown to support digestive, immune and cognitive development in infants by modifying the gut microbiota. ###Infant formula attempts to mimic the nutritional composition of breast milk as closcitracal genericely as possible, and clinical studies have shown that CARE4U 2′-FL can mimic some of the health-promoting effects of HMOs.###The ingredient is produced by microbial fermentation and the final product cbest zinc gluconate supplementontains more than 98% 2′-fucosyllactose, the most abundant of the more than 130 oligosaccharides in human milk.